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Abstract 
As part of measles elimination effort, evaluation of the vaccination program and real-time 
assessment of the epidemic dynamics constitute two important tasks to improve and 
strengthen the control. The present study aimed to develop an epidemiological modeling 
method which can be applied to estimating the vaccine efficacy at an individual level while 
conducting the timely investigation of the epidemic. The multivariate renewal process model 
was employed to describe the temporal evolution of infection by vaccination history, jointly 
estimating the time-dependent reproduction number and the vaccine efficacy. Analyzing the 
enhanced surveillance data of measles in Aichi prefecture, Japan from 2007-08, the vaccine 
efficacy was estimated at 96.7% (95% confidence interval: 95.8, 97.4). Using an age structured 
model, the vaccine efficacy among those aged from 5-19 years was shown to be smaller than 
that among those from 0-4 years. The age-dependent vaccine efficacy estimate informs the 
age-groups to be targeted for revaccination. Because the estimation method can rest on 
readily available epidemiological data, the proposed model has a potential to be integrated 
with routine surveillance. 
Key words: vaccination, epidemiology, measles, mathematical model, vaccine efficacy. 
Introduction 
Although the World Health Organization 
(WHO) and its member states across the world have 
aimed to eliminate measles, the elimination has been 
so far fully successful only in the North American 
region. As the transmission potential of measles is 
extremely high with the estimated basic reproduction 
number of the order of 6-45 [1-4], i.e. the average 
number of secondary cases generated by a single 
primary case in a fully susceptible population being 
6-45, it is necessary to maintain very high vaccination 
coverage to eliminate the infection by means of mass 
vaccination. In industrialized countries, all children 
are subject to routine immunization mostly by the age 
of 18 months using either MR (measles and rubella) or 
MMR (measles, mumps and rubella) vaccine. Moreo-
ver, to boost the vaccine-induced immunity, children 
aged from 4-5 years receive the second dose, and de-
pending on each individual country’s policy, addi-
tional doses/revaccinations are scheduled. 
Understanding the vaccine efficacy at an indi-
vidual level is essential to assess the vaccination pro-
gram. Although the vaccine efficacy against measles is 
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believed to be high (e.g. >95%) [5], in practice even 
vaccinated individuals may be susceptible if the vac-
cination failure occurred or if their vaccine-induced 
immunity waned [6]. If the evaluation can be made 
based on readily available epidemiological datasets in 
real-time, disease control policy making will be able to 
reflect the results of such analysis. For instance, if we 
can detect the signature of a potential major epidemic 
in near future [7] or if we can identify specific 
sub-populations that are less protected than others [8], 
the epidemiological modeling study could improve 
real-time policy making, e.g. identifying an essential 
part of the population to be (re-)vaccinated. 
To estimate the vaccine efficacy, three distinct 
study approaches have been taken. First, laboratory 
measurement (e.g. seroconversion) has been used as a 
surrogate marker of successful immunization, allow-
ing us to judge the vaccine-induced immunity in a 
biologically well-defined manner. However, such 
measurement requires laboratory test samples as well 
as testing capacity, and perhaps more importantly, 
makes it difficult to directly attribute the result to ac-
tual vaccine-induced protection (e.g. actual causal 
impact of vaccination against infection) at an indi-
vidual level [9,10]. Other two approaches thus tackle 
the issue of assessment using epidemiological data. 
Since the epidemiological data of directly transmitted 
infectious diseases involve the technical problem of 
dependent risk of infection between individuals (i.e. 
the so-called “dependent happening”), the empiri-
cally observed datasets are greatly influenced by the 
indirect effect of vaccination [11]. Therefore, as the 
second method, the conditional risks of infection (i.e. 
conditional on an exposure to an infected individual) 
in vaccinated and unvaccinated individuals are com-
pared to estimate the conditional direct effect of vac-
cination while reasonably eliminating the influence of 
indirect effect. For instance, household secondary 
attack proportion (SAP) is conventionally used to es-
timate the efficacy using the conditional risk of infec-
tion given a primary case in households. However, 
collection of household transmission data requires 
substantial observational effort and moreover, such 
study needs to ensure uniform susceptibility among 
household contacts. As the third method, the popula-
tion data may be analyzed by employing a mathe-
matical model that can be believed to have captured 
the underlying transmission dynamics. In particular, 
the final size of an epidemic (i.e. the fraction of the 
total infected individuals in a population throughout 
the course of an epidemic) has been used to estimate 
the efficacy in a highly vaccinated population 
[1,12,13]. However, there has been little attempt to 
estimate the vaccine efficacy jointly with the epidemic 
dynamics in real-time (e.g. during the course of an 
epidemic). 
The present study aims to propose an epidemi-
ological method which we can employ to estimate the 
vaccine efficacy of measles while conducting real-time 
assessment of the epidemic based on readily available 
epidemiological surveillance datasets. While not re-
quiring us to conduct field investigations to specifi-
cally assess the vaccine efficacy, we show that the 
assessment can be partly achieved by analyzing the 
counts of cases with vaccination history over time. 
Materials and Methods 
Epidemiological data 
The present study investigates empirical data 
from Aichi prefecture, around the middle of Japan, 
which has a mild temperate climate and has long 
served as an intersection between the cultures of 
eastern and western Japan. In Japan, children aged 
from 12-24 months had received a single-dose MMR 
vaccination from 1988 to 1993. MMR vaccine was re-
placed by MR vaccine in 1993 due to the reporting of 
the substantial number of abacterial meningitis cases 
that were attributed to MMR vaccination, lowering 
the overall vaccination coverage for a while. In 2006, 
the country initiated the two-dose vaccination pro-
gram in which first and second doses are given at the 
age of 12-24 months and before entering primary 
schools (i.e. before the age of 6 years), respectively. 
Despite nationwide vaccination campaigns, the vac-
cination coverage remained insufficient to prevent the 
epidemic of measles, and only in recent years, the 
vaccination coverage of the first dose clearly exceeded 
95.0% which is believed as the minimum coverage to 
eliminate a disease given the basic reproduction 
number of 20. Due to the presence of the various 
pockets of susceptible individuals, sporadic minor 
outbreaks have been seen continuously across Japan. 
To monitor the outbreaks and strengthen the measles 
control, the Ministry of Health, Labour and Welfare of 
Japan has enhanced the measles surveillance which 
enforced compulsory reporting of all measles cases 
since 2008. Our study rests on the pilot data of the 
enhanced surveillance in Aichi prefecture in 2007 and 
2008. Aichi prefecture was specifically selected as the 
subject in the present study, because the prefecture 
voluntarily launched the enhanced surveillance in 
collaboration with local medical doctors association 
and this was among the earliest in Japan. 
During the surveillance, the confirmed measles 
cases were defined as follows: (condition i) the cases 
who reveal all three specific signs and symptoms (i.e. 
rash, fever and catarrh including coughing, nasal 
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discharge and congestion of conjunctiva) with (condi-
tion ii) laboratory diagnosis based either on (a) isola-
tion of the virus, (b) isolation of the virus RNA, or (c) 
serological diagnosis (i.e. seroconversion of IgM an-
tibody using paired sera). Isolation of confirmed cases 
and contact tracing of all known contacts have been 
made upon confirmatory diagnosis of each case. 
The population size of Aichi prefecture in 2007 
was approximately 7.3 million [14]. The enhanced 
surveillance data included the information regarding 
the date of illness onset (date of fever and date of 
rash), age and vaccination history. Hereafter, we con-
sistently use only the date of fever to describe the 
temporal patterns. In 2007 and 2008, the totals of 212 
and 198 confirmed measles cases were reported, re-
spectively. Due to the enhanced surveillance, these 
numbers correspond to the actual total numbers of 
measles diagnoses in Aichi prefecture. Counting from 
1st January in each year, the epidemic in these years 
revealed a single peak around Days 150 and 125, re-
spectively. A part of the confirmed cases did not re-
member their own vaccination history in the past 
against measles. In 2007, there were 57 vaccinated and 
87 unvaccinated cases that clearly remembered the 
vaccination history, while 68 cases did not remember 
vaccination history. In 2008, there were 50 vaccinated 
and 86 unvaccinated cases with 62 cases without 
known vaccination history. 
Mathematical model 1: Homogeneous popu-
lation 
To develop a real-time estimation framework, 
we first consider a model to describe the transmission 
dynamics of measles in a homogeneously mixing 
population. Let p and  be the vaccination coverage 
and vaccine efficacy, respectively. Usually, the vac-
cination coverage is known, and in the case of Aichi 
prefecture, the baseline coverage of the first dose has 
been estimated at 94.8% [15], while as sensitivity 
analysis we estimate the vaccine efficacy by varying 
the coverage from 90.0 to 99.5%. Let k and l represent 
the vaccination history of an exposed individual and 
the primary case, respectively, for which 1 stands for 
vaccinated and 0 otherwise. We consider the renewal 
process of measles in which the incidence (the number 
of new cases) of those with vaccination history k on 
calendar day t, jk,t is described as 
, , , ,
1
,k t kl t l t
l
j A j 





       …(1) 
where Akl,t,τ describes the rate of causing secondary 
transmissions per single primary case whose vaccine 
status is l among susceptible contacts of those with 
vaccination history k on day t at infection-age τ (i.e. 
the time since infection in each primary case). Let Ut 
represent the vaccine-unrelated frequency of second-
ary transmissions per single primary case on day t, 
which is influenced by all factors other than vaccina-
tion including intrinsic and extrinsic ones. We assume 
that the vaccine efficacy reduces susceptibility of vac-
cinated individuals by (1-) as was adopted in an 
earlier study [12] and assume that Akl,t,τ is separable 
into the functions of t and  as follows: 
0 , ,
1 , ,
(1 ) ,
(1 ) ,
l t t
l t t
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            …(2)  
where gτ is the probability mass function of the gen-
eration time, i.e. the time from infection in a primary 
case to infection in the secondary case caused by the 
primary case, and Akl,t,τ is thus assumed to be scaled 
by p,  and Ut. Based on a published statistical study 
[16], gτ is assumed to be the discrete function that is 
derived from the continuous, lognormal distribution 
with the mean and the standard deviation of 12.0 and 
3.5 days, respectively. The instantaneous reproduc-
tion number, i.e. the average number of secondary 
cases per single primary case at calendar time t, is 
calculated as 
 (1 ) (1 ) ,t tR p p U                …(3) 
which is useful to objectively interpret the epidemic 
curve in real-time, because if the Rt exceeds 1, it 
clearly indicates increase in infections on day t. The 
renewal process in (1) is rewritten as 
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for unvaccinated cases, and 
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for vaccinated cases. 
Due to enhanced surveillance, and because 
measles rarely involves secondary transmissions 
arising from asymptomatic or subclinical cases, the 
number of infected cases is assumed to have been 
fully captured as a function of calendar time. For 
mathematical convenience, we assume that the incu-
bation period is a constant so that the epidemic curve 
can be theoretically shifted leftward for a constant 
period for the purpose of statistical analysis using the 
above mentioned model. In empirical observation, a 
part of cases did not remember vaccination history. 
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Assuming that the past vaccination history is inde-
pendent of possessing a memory of vaccination his-
tory, the probability of knowing vaccination status, q, 
is assumed to be governed by a binomial sampling 
process of the cumulative number of cases with 
known vaccination history among the cumulative 
total of cases. Let h0,t, h1,t and h9,t denote the observed 
numbers of unvaccinated cases, vaccinated cases and 
cases who did not remember vaccination status on 
day t, respectively. We assume that the observed in-
cidence with vaccination history h0,t and h1,t are the 
results of Poisson sampling with expected values 
qE(j0,t;Zt-1) and qE(j1,t;Zt-1), respectively, where 
E(jx,t;Zt-1) denotes the conditional expected value of 
the incidence of cases with vaccination history x on 
day t given the history of observed data (i.e. h0,t, h1,t 
and h9,t) from time 0 up to (t-1), denoted by Zt-1.The 
likelihood function to estimate the reproduction 
number for each date, R, and other parameters q and 
 is written as follows: 
9, 0, 1,
0, 1,
0, 1, 9, ( )
9,
0, 1 1, 1 0, 1 1, 1
0, 1,
( )
( , , ; ) (1 )
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 …(6) 
 
The maximum likelihood estimates of R, q, and  are 
found by minimizing the negative logarithm of (6). 
The 95% confidence intervals are computed based on 
profile likelihood. Maximum likelihood estimation 
was conducted using the statistical package R 
(http://www.r-project.org/) and we used the plkhci 
function from the Bhat package. 
Mathematical model 2: Heterogeneous popu-
lation 
Although the above-mentioned model is kept 
simple, the empirical data suggest that the frequency 
of cases greatly differs by age (Figure 1). Differential 
frequency of cases by age may be attributable to (i) the 
differential population structure, (ii) the different 
contact patterns, (iii) the differential protection con-
ferred by vaccination and so on. Thus we extend the 
above-mentioned model to age-dependent data so 
that the epidemiological dynamics is better captured. 
We take an approximate approach and divide the 
population into three discrete age-groups. Since the 
second-dose vaccination is scheduled by the age of 6 
years with the available social contact data categoriz-
ing the youngest group of children aged from 0-4 
years, and because the adult infections may be sepa-
rated from those in children to clarify the contribution 
of schools to the epidemic, the age groups are classi-
fied as 0-4 years, 5-19 years and 20 years and above, 
respectively. The relative population sizes of the age 
group i, ni are 4.9%, 15.1% and 80.1% in 2007 and 
4.8%, 14.8% and 80.4% in 2008, respectively. Let the 
age-specific incidence of vaccination status k and age 
group a as jka,t on day t, the dynamics is described by 
the multivariate renewal process as follows: 
0 , 0 , 1 ,
0
(1 ) ( )a t a t a ab b t b t
b
j p U n g j j  
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for unvaccinated cases, and 
1 , 0 , 1 ,
0
(1 ) ( )a t a a t a ab b t b t
b
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
 

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
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 ...(8) 
for vaccinated cases. Here {βij} is the normalized con-
tact matrix with the eigenvalue 1, describing the 
age-dependent contact frequency which we retrieve 
from the published result of social contact survey in 
the UK [17]. To address differential contact rates 
across different age-groups, we assume that the 
age-dependent frequency in Aichi with an adjustment 
of the age-dependent population size in Japan is the 
same as that observed in the UK (Table 1). Ut repre-
sents the average number of secondary transmissions 
per single primary case at calendar time t, which is 
influenced by all factors other than vaccination in-
cluding intrinsic and extrinsic ones. The instantane-
ous reproduction number is calculated as the domi-
nant eigenvalue of the 6×6 matrix derived from (7) 
and (8), the analytical solution of which is not very 
insightful in our example, and we focus on estimating 
Ut as a parameter for the heterogeneous model. The 
age-dependent vaccination coverage pa is assumed as 
known, i.e. 97.0, 93.4 and 99.0% for those aged 0-4 
years, 5-19 years, and 20 years and above, respective-
ly. The average of those coverage estimates is greater 
than that for the base-line in the homogeneous setting, 
because the coverage for adults 99.0% is not realisti-
cally tractable due to past natural exposures and 
booster effect [18]. Namely, among adults we assume 
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that the above mentioned coverage denotes the frac-
tion immune or seropositive based on serological 
survey [19]. 
Let h0a,t , h1a,t and h9a,t be the observed incidence of 
unvaccinated cases, vaccinated cases and the cases did 
not remember their own vaccination history in age 
group a on day t. As discussed in the homogeneous 
case, we assume that the vaccination status of the 
cases is independent of remembering their own vac-
cination history, and we also assume that the proba-
bility of having the memory, q is independent of age. 
To estimate U, q and a, we maximize the following 
likelihood:
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0 , 1 ,
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h h
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                       …(9) 
 
where Z represents the history of epidemic data 
across all age-groups. 
 
 
Table 1. The matrix describing the within and between 
age-group frequency of social contact. 
Year 2007 
Age 0-4 5-19 20 and above 
0-4 0.139 0.113 0.440 
5-19 0.037 0.633 0.532 
20 and above 0.027 0.100 0.829 
Year 2008 
Age 0-4 5-19 20 and above 
0-4 0.145 0.118 0.460 
5-19 0.038 0.600 0.561 
20 and above 0.027 0.103 0.828 
The age-groups in the first column represent those of contactee (i.e. 
those who are exposed to cases), while the age-groups in second 
and seventh rows represent those of contactor (i.e. the primary 
cases). The contact is expressed by per unit time (i.e. per day in case 
of this table), although each element is adjusted due to normaliza-
tion. 
 
 
Results 
Figure 1 shows the temporal and age-specific 
distributions of measles cases stratified by vaccination 
history. The epidemic curves in 2007 and 2008 rec-
orded the highest incidence in weeks 22 and 18, re-
spectively. Since there have been very few cases 
nearby new-year and year-end days in both years, 
and due to epidemic in discrete geographic locations, 
we analyzed each epidemic year separately from the 
other, while we focused on the data which combined 
both years when we estimate the vaccine efficacy 
(because the vaccine efficacy is not expected to vary 
greatly by a single year due to limited antigenic di-
versity of measles and small changes in vaccination 
status in the population). The mean (and the standard 
error, SD) and median age of cases (and inter-quartile 
range) were 18.9 (13.9) and 17.0 (10.0-26.0) years in 
2007, respectively. Similarly, the mean and median 
were 14.2 (12.5) and 13.0 (2.0-24.0) years in 2008, re-
spectively. In both years, the cases were aggregated 
among children and very few elderly cases were ob-
served. The cases in 2008 appeared to be significantly 
younger than that in 2007 (p=0.0003, t-test). The pro-
portion of cases who remember as vaccinated was 
26.9% (95% confidence interval (CI): 20.9, 32.9) and 
25.3% (95% CI: 19.2, 31.3), respectively, in 2007 and 
2008, which did not significantly differ by year 
(p=0.76, χ2 test). The proportion of cases who re-
membered either as vaccinated or unvaccinated was 
67.9% (95% CI: 61.6, 74.2) and 68.7% (95% CI: 62.2, 
75.1) in 2007 and 2008, respectively, which was again 
not significantly different by year (p=0.99, χ2 test).  
Figures 2 and 3 show the estimated instantane-
ous reproduction numbers using the homogeneous 
model in 2007 and 2008, respectively, along with the 
visual comparisons between the observed and pre-
dicted epidemic curves with known vaccination his-
tory. The estimated reproduction numbers in early 
and late epidemic phases were very high, reflecting a 
mathematical property of the renewal process, i.e., in 
these time periods, the effective reproduction number 
tends to be very large due to small number of primary 
cases, and thus, we omitted the early estimates in 
Figures 2 and 3. While the majority of the maximum 
likelihood estimates of Rt fell below unity, the upper 
95% confidence interval continuously exceeded 1, 
perhaps reflecting a small number of cases (i.e. sam-
pling error) and high transmission potential of mea-
sles with limited vaccination coverage. Analyzing 
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both years with assumed common vaccination cov-
erage, the maximum likelihood estimates of the vac-
cine efficacy, , was estimated at 96.7% (95% CI: 95.8, 
97.4). The proportion of cases with known vaccination 
history, q, was estimated at 68.3% (95% CI: 65.1, 71.4). 
Even when we estimated  separately by 2007 and 
2008, they were not significantly different:  in 2007 
and 2008 was 96.5% (95% CI: 95.2, 97.5) and 96.8% 
(95% CI: 95.5, 97.8), respectively.  
When we employed the age-heterogeneous 
model, the vaccine efficacy was separately estimated 
for each age-group. The maximum likelihood esti-
mates of the vaccine efficacy 1, 2 and 3 for those 
aged 0-4 years, 5-19 years, and 20 years and above 
were 97.9% (95% CI: 95.8, 99.0), 93.4% (95% CI: 89.0, 
96.1) and 99.6% (95% CI: 99.2, 99.8), respectively. The 
proportion of cases with known vaccination history, q, 
was estimated to be 68.1% (95% CI: 65.2, 70.9). As the 
model captures the time-dependency, the good-
ness-of-fit and the estimates of the reproduction 
number did not greatly differ from those shown in 
Figures 2 and 3 (Results not shown). 
Since we cannot directly estimate the exact vac-
cination coverage among those involved in the con-
tact, the sensitivity analysis was conducted (Figure 4). 
Within the assumed range of vaccination coverage 
(90.0%-99.5%), the maximum likelihood estimate of 
the vaccine efficacy ranged 93.3%-99.7%. The esti-
mated vaccine efficacy increased as the vaccination 
coverage increased. The reason for positive relation-
ship in Figure 4 is intuitively understood from equa-
tions (4) and (5). That is, if we take the ratio of the 
incidence of unvaccinated to vaccinated, we get 
0,
1,
1 1
.
1
t
t
j p
j p 



           …(10) 
The left-hand side of equation (10) corresponds to the 
observed data which is a constant on a single day 
(given empirical data). If we increase the vaccination 
coverage p, then (1-p)/p decreases and this necessi-
tates 1/(1-) to increase in equation (10) or forces the 
vaccine efficacy  to increase. 
 
 
Figure 1. The time and age-specific distributions of the measles outbreak in Aichi prefecture, Japan, from 2007-08. A & 
B. The temporal distribution of measles cases. The week 1 corresponds to the week that includes 1st January. C & D. The age distribution 
of measles cases. In all panels, the vaccinated and unvaccinated correspond to the cases who clearly remembered as previously vaccinated 
and unvaccinated, respectively. Unknown represents the cases who did not remember vaccination history at the time of diagnosis of 
measles. 
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Figure 2. The estimated instantaneous reproduction numbers and visual comparisons between the observed and pre-
dicted temporal distributions by known vaccination history in 2007. A. The maximum likelihood estimates (circles) and the 
upper 95% confidence interval (steps) of the instantaneous reproduction number. The horizontal axis is expressed as the calendar date in 
which 1st January is set to be 0. The horizontal grey line shows the level at which Rt = 1. For mathematical reasons Rt is unrealistically high 
during the very early and late epidemic phases, and thus, the estimates are omitted from this panel. B, C and D. Comparisons between 
observed and predicted temporal distributions of cases. B and C compare cases who were known to be vaccinated and unvaccinated, 
respectively. D shows the cases who did not remember vaccination history at the time of diagnosis of measles. The week 1 corresponds 
the week that includes 1st January. 
 
Discussion 
The present study proposed a simple method to 
estimate the vaccine efficacy against measles, jointly 
quantifying the parameters governing the temporal 
evolution of measles. The method uses only the epi-
demiological surveillance data with partial infor-
mation of vaccination history, which can rest on read-
ily available datasets and is not as costly as conduct-
ing specialized field study such as that observing 
household transmissions. To capture the realistic as-
pect of measles transmission, the extended model 
accounted for age-dependent heterogeneity [20-22]. 
Although not significant, the vaccine efficacy among 
those aged 5-19 years was shown to be smaller than 
that in children aged below 5 years, which may per-
haps reflect the waning immunity among school 
children [23]. Given Figure 4 and considering that the 
actual vaccination coverage can be lower than that in 
literature due to cessation of MMR vaccine in 1993, 
the assumed coverage of 93.4% may be suggestive of 
potential overestimation of vaccine efficacy (if the 
actual vaccination coverage is lower), but not of un-
derestimation. Therefore, the straightforward policy 
implication is that one may target school children 
aged 5-19 for (re-)vaccination to eliminate the pockets 
of susceptible individuals. 
As the proposed method can rest on the readily 
available data (i.e. routinely collected surveillance 
data), we believe that the model has a potential to be 
integrated with the routine surveillance practice of 
measles across the world. In particular, the proposed 
method permits the presence of missing data for vac-
cination history with an assumption of missing com-
pletely at random (MCAR), which has not been ex-
plicitly dealt with in earlier modeling studies. While 
various mathematical approaches have been pro-
posed to model the measles epidemic, the present 
study offered advancement in two different aspects. 
First, although many studies analyzed the transmis-
sion dynamics using mathematical models, the objec-
tives of those studies have been different from the 
efficacy estimation, and they frequently focused on 
the estimation of time-dependent notification charac-
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teristics [24] or clarification of the kinetics of measles 
transmission using mathematical model [25]. The 
present study has shown that the vaccine efficacy is 
very conveniently estimated, assuming that the de-
pletion of susceptible individuals is negligible. Se-
cond, whereas a few other studies estimated the vac-
cine efficacy, including that based on final size [1,4] 
and an explicit modeling of epidemic dynamics [26], 
the present study is the first to have jointly conducted 
the vaccine efficacy estimation and the real-time as-
sessment of an epidemic, by estimating the effective 
reproduction number Rt along with the vaccine effi-
cacy parameter. In other words, our proposed ap-
proach not only helps assess vaccine efficacy but 
permits us to interpret the temporal evolution in an 
objective manner. 
 
Figure 3. The estimated instantaneous reproduction numbers and visual comparisons between the observed and pre-
dicted temporal distributions by known vaccination in 2008. A. The maximum likelihood estimates (circles) and the upper 95% 
confidence interval (steps) of the instantaneous reproduction number. The horizontal axis is expressed as the calendar date in which 1st 
January is set to be 0. The horizontal grey line shows the level at which Rt = 1. For mathematical reasons Rt is unrealistically high during the 
very early and late epidemic phases, and thus, the estimates are omitted from this panel. B, C and D. Comparisons between observed and 
predicted temporal distributions of cases. B and C compare cases who were known to be vaccinated and unvaccinated, respectively. D 
shows the cases who did not remember vaccination history at the time of diagnosis of measles. The week 1 corresponds the week that 
includes 1st January. 
 
 
 
Figure 4. Sensitivity of vaccine efficacy to the vaccination cov-
erage. Solid line represents the maximum likelihood estimate, while 
dashed lines are the upper and lower 95% confidence intervals of vaccine 
efficacy. The 95% confidence intervals were derived from profile likeli-
hood. Although we show the results from homogeneous model, the 
qualitative patterns of age-heterogeneous model are not different. 
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However, the following three remarks should be 
noted as technical limitations. First, we successfully 
estimated the vaccine efficacy as well as Rt, but we did 
so assuming that the depletion of susceptible indi-
viduals is negligible. We believe that this assumption 
is reasonable because the number of cases in Aichi 
remained very small as compared to the population 
size of unvaccinated individuals who can be theoret-
ically considered as fully susceptible [27], and also 
because the epidemic data in question were seen in a 
population which was large enough. However, the 
model cannot capture detailed heterogeneous trans-
mission such as local depletion of susceptible indi-
viduals (e.g. due to formation of a cluster) and thus, 
the proposed method may not be directly applicable 
to outbreaks in a very small population. Second, we 
did not account for detailed revaccination schedules 
in Japan due to impossibility of precisely tracking the 
fraction of unvaccinated susceptible individuals as a 
function of age. The number of doses may have a 
profound impact on vaccine efficacy, but unfortu-
nately we did not have access to the dose data for each 
confirmed case. Third, the proposed model assumes a 
closed population, i.e., without emigration and im-
migration. However, obviously the observed data 
must have involved imported cases. From modeling 
perspectives, the host migration has little impact on 
the estimate of vaccine efficacy, while it would influ-
ence the estimates of Rt [28]. Given the individual case 
record for the entire country in the future, one can 
analyze the dynamics, explicitly accounting for the 
geographic spread of measles across Japan. 
Despite such limitations, we believe that the re-
al-time assessment of epidemic dynamics with 
(age-specific) estimates of vaccine efficacy based on 
readily available surveillance datasets would be the 
huge advantage for epidemiological monitoring of 
measles in any vaccination population. As was seen in 
age-dependent vaccine efficacy, the proposed method 
could inform useful vaccination policy to objectively 
curb the measles epidemic in real-time. If measles 
vaccination is compulsory, the finding will directly 
lead to deciding the host for revaccination, and if 
voluntary, the self- and group-interests may have to 
be balanced [29-31]. At the very least, we believe that 
the proposed approach can supplement the existing 
evaluation methods of vaccine efficacy. 
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